The Rundown: ExL’s Blog
Viewing 41 to 50 of 182 records.
Last Week to Save for the 12th Partnering With ACOs & IDNs Summit!
Tuesday September 18th, 2018
Prices increase this Friday, September 21 for the 12th Partnering With ACOs & IDNS Summit, taking place October 29–30 in Los Angeles. This one-of-a-kind event will teach attendees to utilize real-world evidence, risk-based outcomes, specialty care, and population health in risk-sharing partnerships with innovative sessions from companies like Pfizer, Sanofi, Sunovion, and Genentech. Download our brochure for more details and reserve your seat today to take advantage of our Early Bird discount and save $200 off the standard registration rate. Be sure to use Priority Code 790218BLOG when signing up.
SCOTT HYLLA, Director,…
AI Innovations for Life Science Summit West Early Prices Expire This Week!
Monday September 17th, 2018
Prices increase this Friday for the AI Innovations for Life Science Summit West, taking place November 6–7 in San Francisco. This event will bring together a speaking faculty of biomedical experts in digital health, machine learning, and blockchain-based systems that have harnessed the potential of artificial intelligence applications in drug development and other aspects of the industry.
RONALD DORENBOS, Associate Director Materials and Innovation, TAKEDA
IRENE CHOI, PH.D., Director, Drug Discovery, VERGE GENOMICS
ARIS PERSIDIS, President, BIOVISTA
GEORGIA MITSI, Senior Director, Search Evaluation, Digital Healthcare, SUNOVION PHARMACEUTICALS INC.
RYAN BILLINGS, Senior Director, Digital…
Learn Abuse-Deterrence Breakthroughs From Cannabis, Stimulants, and Other Drugs of Abuse
Thursday August 30th, 2018
As fears of opioid addiction grow, physicians may be more willing to rely on increasingly legal cannabis rather than opioids. But has the uptake of cannabis since legalization led to adverse health outcomes — even mortality spikes? What are the most important lessons on abuse-deterrence that cannabis, stimulants, and other drugs of abuse can offer to the opioid crisis?
The 5th Human Abuse Liability Testing & Market Access Summit (Nov. 5–6, Herndon, VA) is the only industry event to fully cover mechanisms to document and reduce the abuse risks of pain therapeutics and CNS-active drugs. Learn it here before…
FDA Presents on Expectations for CDER-BIMO Inspections of Clinical Investigators and Sponsors
Wednesday August 29th, 2018
The FDA has just confirmed their participation as a featured speaker at the 9th Clinical Quality Oversight Forum on October 10–12 in Philadelphia.
Register today to secure your place. Click here and use Priority Code CQOF-BLOG2.
From early R&D to commercialization, our speaking faculty will dive into examples of…
From The Blog